| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
|
|
|
|
|||||||||||||
|
|
|||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
INFLAMMATORY BOWEL DISEASE |
1 Department of Animal Science, University of Manitoba, Winnipeg, Manitoba, Canada
2 Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, Manitoba, Canada
3 Faculty of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada
Correspondence to:
Correspondence to:
Dr DO Krause
Department of Animal Science, 236 Animal Science Building, University of Manitoba, Winnipeg, MB, Canada R3T 2N2; denis_krause{at}umanitoba.ca
Background: It is not clear which species of bacteria may be involved in inflammatory bowel disease (IBD). One way of determining which bacteria might be likely candidates is to use culture-independent methods to identify microorganisms that are present in diseased tissues but not in controls.
Aims: (1) To assess the diversity of microbial communities of biopsy tissue using culture-independent methods; (2) to culture the bacteria found in the tissues of patients with IBD but not in the controls; (3) to identify potential virulence factors associated with cultured bacteria.
Methods: 84 biopsy specimens were collected from 15 controls, 13 patients with Crohn’s disease (CD) and 19 patients with ulcerative colitis (UC) from a population-based case–control study. Ribosomal intergenic spacer analysis (RISA) was conducted to identify unique DNA bands in tissues from patients with CD and UC that did not appear in controls.
Results: RISA followed by DNA sequencing identified unique bands in biopsy specimens from patients with IBD that were classified as Escherichia coli. Targeted culture showed a significantly (p<0.05) higher number of Enterobacteriaceae in specimens from patients with IBD. The B2+D phylogenetic group, serine protease autotransporters (SPATE) and adherence factors were more likely to be associated with tissues from patients with UC and CD than with controls.
Conclusions: The abundance of Enterobacteriaceae is 3–4 logs higher in tissues of patients with IBD and the B2+D phylogenetic groups are more prevalent in patients with UC and CD. The B2+D phylogenetic groups are associated with SPATE and adherence factors and may have a significant role in disease aetiology.
Abbreviations: CD, Crohn’s disease; IBD, inflammatory bowel disease; PAI, pathogenicity island; RFLP, restriction fragment length polymorphism; RISA, ribosomal intergenic spacer analysis; SPATE, serine protease autotransporters; UC, ulcerative colitis
Relevant Article
Gut 2007 56: 610-612.
This article has been cited by other articles:
|
|
 |
|
  C. N Bernstein and F. Shanahan Disorders of a modern lifestyle: reconciling the epidemiology of inflammatory bowel diseases Gut, September 1, 2008; 57(9): 1185 - 1191. [Full Text] [PDF]
|
|
|
|
 |
|
 C. Bronowski, S. L. Smith, K. Yokota, J. E. Corkill, H. M. Martin, B. J. Campbell, J. M. Rhodes, C. A. Hart, and C. Winstanley A subset of mucosa-associated Escherichia coli isolates from patients with colon cancer, but not Crohn's disease, share pathogenicity islands with urinary pathogenic E. coli Microbiology, February 1, 2008; 154(2): 571 - 583. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Subramanian, C. L. Roberts, C. A. Hart, H. M. Martin, S. W. Edwards, J. M. Rhodes, and B. J. Campbell Replication of Colonic Crohn's Disease Mucosal Escherichia coli Isolates within Macrophages and Their Susceptibility to Antibiotics Antimicrob. Agents Chemother., February 1, 2008; 52(2): 427 - 434. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
